Organisation mondiale de la santé (OMS) · Technical Documents

WHO collaborative studies : guide for the control of emergencies caused by yellow fever in Africa, Dakar, 30 May to 3 June 1983

Organisation mondiale de la santé
Voir le document original

Le texte intégral est hébergé par l’organisation qui le publie. lawenc.com indexe les métadonnées et renvoie vers la source officielle.

Texte intégral

//^ïlk\

WORLD H L A L T H ORGANIZATION OK(;ANISATIQN MONDIALE DE L A SANTE

VIR/YF/83.1 ENGLISH ONLY

GUIDE FOR THE CONTROL OF EMERGENCIES CAUSED BY YELLOW FEVER I N AFRICA Dakar, 30 May t o 3 June 1983 D r a f t Agenda Item 9

INDEXED

WHO COLLABORATIVE STUDIES by Dr P. Brès, I n s t i t u t P a s t e u r , Paris

I t i s perhaps t h e s u c c e s s f u l development o f a s a f e and v e r y e f f i c i e n t v a c c i n e which has slowed down f u r t h e r r e s e a r c h on y e l l o w f e v e r d u r i n g t h e p a s t t h r e e decades. As a r e s u l t , there are s e v e r a l important aspects of y e l l o w f e v e r which are s t i l l l i t t l e understood. Research has a l s o made l i t t l e p r o g r e s s because t h e d i s e a s e i s m a i n l y o b s e r v e d i n remote r e g i o n s , c l o s e to i t s s y l v a t i c c y c l e , where l a b o r a t o r y c a p a b i l i t i e s a r e m i s s i n g . Whenever t h e v i r u s causes an e p i d e m i c t h e most v a l u a b l e m a t e r i a l w h i c h would be a v a i l a b l e cannot be c o m p l e t e l y u t i l i z e d because r e s e a r c h was n o t o r g a n i z e d i n advance and o n l y immediate c o n t r o l a c t i v i t i e s are s e t i n m o t i o n d u r i n g t h e o u t b r e a k . The o b j e c t o f t h i s s e c t i o n i s t o p i n p o i n t some o f t h e i m p o r t a n t q u e r i e s w h i c h c o u l d be s t u d i e d d u r i n g the n e x t e p i d e m i c s o r d u r i n g t h e i n t e r - e p i d e m i c p e r i o d . They c o n c e r n t h e v i r u s i t s e l f , i t s e c o l o g y , t h e d i s e a s e , i t s t r e a t m e n t and the v a c c i n e . 9.1 Virological studies

Recent s t u d i e s have p r o v i d e d a b e t t e r i n s i g h t i n t o t h e m o l e c u l a r s t r u c t u r e o f t h e v i r u s and t h e components which d e t e r m i n e i t s a n t i g e n i c i t y . F u r t h e r s t u d i e s a r e n e c e s s a r y to e l u c i d a t e the d i f f e r e n c e i n v i r u l e n c e w h i c h seems t o e x i s t between s y l v a t i c s t r a i n s and epidemic s t r a i n s . T h i s might be due t o t h e passage h i s t o r y between v e r t e b r a t e s and i n v e r t e b r a t e s a t d i f f e r e n t t e m p e r a t u r e s and a t d i f f e r e n t r a p i d i t y . The a t t a c h m e n t s i t e o f t h e v i r u s to t h e s u r f a c e o f s e n s i t i v e c e l l s might be s t u d i e d . 9 .2 Ecological studies

An i m p o r t a n t p r o g r e s s has r e c e n t l y shown how t h e c i r c u l a t i o n o f t h e v i r u s i s enhanced a t the b e g i n n i n g o f t h e r a i n y season and t h e d i f f e r e n t r o l e p l a y e d by s e v e r a l s y l v a t i c m o s q u i t o species. The maintenance o f t h e v i r u s d u r i n g t h e d r y s e a s o n seems t o be e x p l a i n e d by t h e t r a n s o v a r i a l t r a n s m i s s i o n i n m o s q u i t o o r by l o n g - t e r m i n f e c t i o n of o t h e r a n i m a l s such as t i c k s and p o s s i b l y some s t i l l u n c o v e r e d v e r t e b r a t e s such as t h e hedgehog, whose p o s s i b l e r o l e has been f o r g o t t e n . The a v a i l a b i l i t y o f more s e n s i t i v e methods f o r i s o l a t i o n o f t h e v i r u s i n c e l l c u l t u r e o r i n m o s q u i t o s s h o u l d be u t i l i z e d f o r such s t u d i e s . The g e n e t i c c h a r a c t e r i z a t i o n of m o s q u i t o s has a l s o p r o g r e s s e d . I t i s fortunate, but n o n e t h e l e s s p u z z l i n g , t h a t t h e urban Aedes a e g y p t i w h i c h p r o l i f e r a t e s a t p r e s e n t i n c i t i e s , and i t s c o u s i n i n t h e nearby f o r e s t have s t a y e d i n d i f f e r e n t t o t h e e p i z o o t i c waves o f s y l v a t i c y e l l o w f e v e r i n West and C e n t r a l A f r i c a . A r e they s t i l l a b l e to t r a n s m i t y e l l o w f e v e r o r a r e they g e n e t i c a l l y i m p o t e n t , o r does t h e today new v i r u s n o t l i k e them? The d i f f e r e n c e i n a b i l i t y f o r t r a n s m i s s i o n o f y e l l o w f e v e r o f Aedes a e g y p t i and Aedes s i m p s o n i i n West and E a s t A f r i c a d e s e r v e s f u r t h e r s t u d y .

The

issue

ot

this document does not It should without not the be

constitute reviewed, of

Ce Il

document ne doit ni

ne

constitue pas une publication. rendu ou

formal

publication. or quoted Health for

faire l'objet d'aucun compte d'aucune citation mondiale

abstracted the are World

agreement Authors in

résumé

sans l'autorisation de Les opinions que

Organization. views

alone signed

l'Organisation exprimées

de la Santé.

responsible

expressed

dans

les articles signés n'engagent

articles.

leurs auteurs.

VI R/YF / 8 3 . 1 page 2 Stud y of the disease The clini ca l aspe c t s o f t he di sease have be en des c ribed wi t h man y r efi nements for three cen t urie s and thi s i s s t i ll continuin g in re ce nt epidemi cs but no progress has b ee n mad e in the s tud y of the ph ys i o-path olog i ca l co ndition . I s th e haemorrhagic diathesis primary or secondary to liver infection? Is the vas cular collapse a nd dea th in hy po thermia similar to the sh ock syndrome of dengue haemo rrhag i c feve r, which a l so show s Co un c ilman b odies in liver sections? Do the parenchymatous lesions prec ede the mese nchymat ous and reticuloendotheli a l pro liferation of the virus or vice-versa? Are the renal l es i ons of an imrnunocomplex nature or c aused by autoimrnunity? A battery of tests mi ght be devised in advance to throw some light on these points when an outbreak provides during a few day s the material for such studies. Fortunately, most patients suffer from a mild form of the disease. Is there a genetic Did their previous infection with other flavivirus play an explanation in the HLA system? adverse or favourable role? Treatment At present, the therapy is mainly sy mptomati c and dire c t ed t o liver function, clotting factors and renal clearance. Chemical antivirals are appearin g , interferon becomes more easily available and protocols for trial of such drugs should be elaborated in advance. A beneficial effect has been attributed to immune pl asma o r immun og lobulins in Bo livian haemorrhagic fever, in Ebola haemorrhagic fever and In Lassa fe ver, when admini s tered early in the disease . Would it be so with yellow fever? Vaccine improvement A WHO-PAHO meeting held in IJashington in 1981 anal yse d the present bott le-n ecks in th e production of the traditional vaccine and proposed i ts modernization by adaptation of the modern t echnology for cell culture vaccines . The progress should bear on enhancing the yield (which will decrease the price and inc rea se the availabilit y of the vacc ine), improving the thermostability, dec rea si ng the ri s k of si de-ef fects and permitting the administration by scarification. The application of geneti c engineering methods would also cons iderably improve th e yield of an immunizin g specifi c pro tein, but a killed vaccine might r equire several doses, which might or might not be a disadvanta ge in comparison with an improved live vaccin e. Collaborative studies The necessary technology for these studies has re cently made great progress and a full use of it implies a multidisciplinary coordinated research. Such a col laborative re search under the aegis of WHO proved s uccessful for the study o f th e immunopathological mechanisms of dengue haemorrhagic fever. Collaborative protocols might be defined with WHO assistance involvin g several gr oups of s cientists in such collabora tive multidisciplinary studies of yellow fever.

Informations clés
Type de document Technical Documents
Date d'adoption
Source Organisation mondiale de la santé